GPT Healthcare recently conducted its 36th Annual General Meeting. Shareholders adopted the audited financial statements for the fiscal year ended March 31, 2025. Key approvals included the confirmation of an interim dividend of ₹1 per share and the declaration of a final dividend of ₹1.50 per share for FY 2024-25, directly benefiting investors. Additionally, re-appointments and remuneration for auditors and key managerial personnel were approved, alongside variations in employment terms for the Executive Chairman and Executive Director, and consultancy fees for certain directors. This meeting addressed routine corporate governance matters and shareholder distributions.